Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

SCN1A – Developmental and Epileptic Encephalopathy

SCN1A encodes the Nav1.1 voltage-gated sodium channel alpha subunit, whose dysfunction leads to a spectrum of epileptic disorders including developmental and epileptic encephalopathy (MONDO:0100062). Pathogenic SCN1A variants disrupt neuronal excitability through loss- or gain-of-function effects, causing early-onset, refractory seizures and neurodevelopmental impairment.

Clinical Validity

The SCN1A–DEE association is classified as Strong based on multiple lines of evidence. Over 50 unrelated DEE probands harbor SCN1A variants: 13 point mutations in 12 probands (PMID:18413471), 38 probands in a cohort of infantile-onset DEE (PMID:34859793), and additional AR cases in affected siblings (PMID:39200163). Several variants are de novo truncating or splice changes with predicted null effect; biallelic missense variants segregate in families with autosomal recessive inheritance. Concordant functional assays across studies further support pathogenicity.

Genetic Evidence

Inheritance is predominantly autosomal dominant with de novo loss-of-function. A subset of SCN1A variants shows autosomal recessive inheritance in consanguineous families, with segregation in two affected siblings (PMID:39200163). Case series include 12 cryptogenic epileptic encephalopathy probands with 13 distinct point mutations (PMID:18413471) and 38 early-infantile-onset DEE probands with SCN1A mutations (PMID:34859793). Variant spectrum spans truncating (nonsense, frameshift), missense, and splice site changes.

Representative variant: c.2803A>T (p.Asn935Tyr) (PMID:39200163).

Functional / Experimental Evidence

Multiple electrophysiological studies in heterologous systems demonstrate that SMEI- and DEE-associated SCN1A missense and truncating mutations abolish or severely attenuate Na+ currents (PMID:14672992; PMID:9422778). A knock-in mouse model carrying the recurrent R1648H gain-of-function mutation exhibits spontaneous seizures, interneuron hypoexcitability, and premature mortality, mirroring human DEE (PMID:20100831). Concordance between biophysical defects and clinical severity underscores a loss-of-function mechanism in interneurons leading to network hyperexcitability.

Integration and Conclusion

SCN1A variants cause DEE through dominant de novo loss-of-function and, less commonly, recessive hypomorphic alleles. Robust genetic evidence from >50 probands, familial segregation, and extensive functional characterization support a Strong gene-disease relationship. Diagnostic sequencing of SCN1A is recommended in early-onset, drug-resistant epileptic encephalopathy. Early molecular diagnosis informs prognosis, guides avoidance of sodium channel blockers, and enables targeted therapies.

Key Take-home: SCN1A testing is clinically essential for early diagnosis and personalized management of developmental and epileptic encephalopathy.

References

  • Archives of neurology • 2008 • Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified PMID:18413471
  • Epileptic disorders • 2022 • Phenotypic spectrum and long-term outcome of children with genetic early-infantile-onset developmental and epileptic encephalopathy PMID:34859793
  • Biomedicines • 2024 • The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam PMID:39200163
  • Cureus • 2024 • Deciphering the Complexities of Sodium Voltage-Gated Channel Alpha Subunit 1 (SCN1A) Mutation: A Case of Intractable Epilepsy in a Five-and-a-Half-Month-Old Male PMID:39119390
  • The Journal of biological chemistry • 1998 • A critical role for the S4-S5 intracellular loop in domain IV of the sodium channel alpha-subunit in fast inactivation PMID:9422778
  • The Journal of neuroscience • 2003 • Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A PMID:14672992
  • The Journal of biological chemistry • 2010 • Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities PMID:20100831

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

Over 50 unrelated DEE probands with SCN1A variants, including de novo LoF and segregating AR cases; concordant functional data

Genetic Evidence

Strong

13 point mutations in 12 probands (PMID:18413471), 38 probands (PMID:34859793), segregation in AR siblings (PMID:39200163)

Functional Evidence

Strong

Patch-clamp studies show SCN1A LoF (PMID:14672992;9422778), R1648H knock-in mouse recapitulates DEE (PMID:20100831)